top of page
KUSURSUZ KALİTE MUTLAK GÜVENLİK (1246 x 413 piksel).png

Regenyal Technology: Natural Excellence Through Science

What sets Regenyal products apart from competitors in the medical aesthetics market is their respect for tissue and their innovative production methodology.

Here are the 4 pillars that make Regenyal the "gold standard":

​

1. Gentle Cross-linking

Regenyal products are manufactured with a special cross-linking procedure carried out at low temperature over an extended period.

This "gentle" process preserves the structure of the hyaluronic acid chains while maximising the product's biocompatibility with tissue.

​

2. 30% Less BDDE: Maximum Safety

The amount of BDDE (cross-linking agent), the most critical safety indicator for physicians,

is 30% lower in Regenyal products than in competing products. Low chemical residue minimises the risk of post-treatment oedema and inflammation, allowing you to offer your patients the purest form.

​

3. Homogeneous Diffusion 

Thanks to the slow mixing process, the gel diffuses homogeneously from the moment it is injected beneath the tissue.

This technology prevents the "artificial" look after filling, delivering an aesthetic result that integrates with the tissue without affecting natural expressions.

​

4. Ideal Viscosity Through Multifractional Formulation

Regenyal combines hyaluronic acid fractions of different molecular weights. This special formulation provides:

​

  • Tissue compatibility: Optimises the product's viscosity according to the density of the target tissue.

  • Optimal longevity: Combines the most natural look with the longest-lasting result.

  • Monophasic fluid gel: With a smooth gel structure completely free of residues, it settles flawlessly under the tissue without forming lumps.

pattentli teknoloji (2).png

Biorevolumetric Technology: Cellular and Structural Restoration of Tissue

Biorevitalising volumetric products are monophasic gels obtained by combining hyaluronic acids of different molecular weights through gentle cross-linking technology.

 

This advanced production method creates a three-dimensional structure with ideal viscosity.

​

Carried out at low temperature, the process keeps depolymerisation of the sodium hyaluronate raw material to a minimum, preserving its rheological properties while reducing the amount of cross-linking agent required.

​

The intercalation technique protects linear hyaluronic acid from enzymatic degradation, helping biological activity to last longer.

​

With a smaller particle structure than conventional fillers, these products integrate more homogeneously with the tissue and diffuse in a controlled way.

​

This eliminates the risk of a stringy appearance, providing a more natural and balanced volumising effect.

​

Thanks to the innovative production process, an average of 30% less BDDE is used compared with standard fillers of similar viscosity.

 

As a result, free cross-linker residue is kept below 0.1 PPM, ensuring a high safety profile.

bottom of page